Akorn (AKRX) in Focus: Stock Moves 5.0% Higher - Tale of the Tape

By Zacks Equity Research,

Shutterstock photo

Akorn, Inc. ( AKRX ) was a big mover last session, as the company saw its shares rise by over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has now gained over 28% since Feb 5.

This drug manufacturer has seen no estimate revision over the past 30 days and its Zacks Consensus Estimate remained unchanged over the same time frame. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Akorn currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the same industry include Mallinckrodt plc ( MNK ), Actavis plc ( ACT ) and Dr. Reddy's Laboratories Ltd. ( RDY ). While Mallinckrodt holds a Zacks Rank #1 (Strong Buy), Actavis and Dr. Reddy's Laboratories carry a Zacks Rank #2 (Buy

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

ACTAVIS PLC (ACT): Free Stock Analysis Report

AKORN INC (AKRX): Free Stock Analysis Report

MALLINCKRODT PL (MNK): Free Stock Analysis Report

DOCTOR REDDYS (RDY): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks
Referenced Stocks: ACT , AKRX , MNK , RDY

More from Zacks.com




Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by BankRate.com